|
1
|
Martin-Gayo E and Yu XG: Role of Dendritic
Cells in Natural Immune Control of HIV-1 Infection. Front Immunol.
10:13062019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carenza C, Calcaterra F, Oriolo F, Di Vito
C, Ubezio M, Della Porta MG, Mavilio D and Della Bella S:
Costimulatory molecules and immune checkpoints are differentially
expressed on different subsets of dendritic cells. Front Immunol.
10:13252019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hayati AR and Zulkarnaen M: An
immunohistochemical study of CD1a and CD83-positive infiltrating
dendritic cell density in cervical neoplasia. Int J Gynecol Pathol.
26:83–88. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poindexter NJ, Sahin A, Hunt KK and Grimm
EA: Analysis of dendritic cells in tumor-free and tumor-containing
sentinel lymph nodes from patients with breast cancer. Breast
Cancer Res. 6:R408–R415. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishigami S, Natsugoe S, Uenosono Y, Hata
Y, Nakajo A, Miyazono F, Matsumoto M, Hokita S and Aikou T:
Infiltration of antitumor immunocytes into the sentinel node in
gastric cancer. J Gastrointest Surg. 7:735–739. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greenhough A, Smartt HJ, Moore AE, Roberts
HR, Williams AC, Paraskeva C and Kaidi A: The COX-2/PGE2 pathway:
Key roles in the hallmarks of cancer and adaptation to the tumour
micro-environment. Carcinogenesis. 30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang MT, Honn KV and Nie D:
Cyclooxygenases, prostanoids, and tumor progression. Cancer
Metastasis Rev. 26:525–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee EJ, Kim SJ, Hahn YI, Yoon HJ, Han B,
Kim K, Lee S, Kim KP, Suh YG, Na HK, et al: 15-Keto prostaglandin
E2 suppresses STAT3 signaling and inhibits breast cancer cell
growth and progression. Redox Biol. 23:1011752019. View Article : Google Scholar :
|
|
9
|
Uefuji K, Ichikura T and Mochizuki H:
Cyclooxygenase-2 expression is related to prostaglandin
biosynthesis and angio-genesis in human gastric cancer. Clin Cancer
Res. 6:135–138. 2000.PubMed/NCBI
|
|
10
|
Watson J and Chuah SY: Prostaglandins,
steroids and human mammary cancer. Eur J Cancer Clin Oncol.
21:1051–1055. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sales KJ, Katz AA, Davis M, Hinz S,
Soeters RP, Hofmeyr MD, Millar RP and Jabbour HN: Cyclooxygenase-2
expression and prostaglandin E(2) synthesis are up-regulated in
carcinomas of the cervix: A possible autocrine/paracrine regulation
of neoplastic cell function via EP2/EP4 receptors. J Clin
Endocrinol Metab. 86:2243–2249. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saalbach A, Janik T, Busch M, Herbert D,
Anderegg U and Simon JC: Fibroblasts support migration of
monocyte-derived dendritic cells by secretion of PGE2 and MMP-1.
Exp Dermatol. 24:598–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yen JH, Khayrullina T and Ganea D:
PGE2-induced metallo-proteinase-9 is essential for dendritic cell
migration. Blood. 111:260–270. 2008. View Article : Google Scholar
|
|
14
|
Li Y, Huang K, Ji PL, Song L and Liu HT:
Cervical Infection of Oncogenic Human Papillomavirus (HPV) Types in
Beijing, China. Biomed Environ Sci. 29:734–741. 2016.PubMed/NCBI
|
|
15
|
Song D, Li H, Li H and Dai J: Effect of
human papillomavirus infection on the immune system and its role in
the course of cervical cancer. Oncol Lett. 10:600–606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guess JC and McCance DJ: Decreased
migration of Langerhans precursor-like cells in response to human
keratinocytes expressing human papillomavirus type 16 E6/E7 is
related to reduced macrophage inflammatory protein-3alpha
production. J Virol. 79:14852–14862. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caberg JH, Hubert P, Herman L, Herfs M,
Roncarati P, Boniver J and Delvenne P: Increased migration of
Langerhans cells in response to HPV16 E6 and E7 oncogene silencing:
Role of CCL20. Cancer Immunol Immunother. 58:39–47. 2009.
View Article : Google Scholar
|
|
18
|
Subbaramaiah K and Dannenberg AJ:
Cyclooxygenase-2 transcription is regulated by human papillomavirus
16 E6 and E7 oncoproteins: Evidence of a corepressor/coactivator
exchange. Cancer Res. 67:3976–3985. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lutz MB, Kukutsch N, Ogilvie AL, Rössner
S, Koch F, Romani N and Schuler G: An advanced culture method for
generating large quantities of highly pure dendritic cells from
mouse bone marrow. J Immunol Methods. 223:77–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han P, Hanlon D, Sobolev O, Chaudhury R
and Edelson RL: Ex vivo dendritic cell generation-A critical
comparison of current approaches. Int Rev Cell Mol Biol.
349:251–307. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baratelli FE, Heuzé-Vourc'h N, Krysan K,
Dohadwala M, Riedl K, Sharma S and Dubinett SM: Prostaglandin
E2-dependent enhancement of tissue inhibitors of
metalloproteinases-1 production limits dendritic cell migration
through extracellular matrix. J Immunol. 173:5458–5466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghittoni R, Accardi R, Hasan U, Gheit T,
Sylla B and Tommasino M: The biological properties of E6 and E7
oncoproteins from human papillomaviruses. Virus Genes. 40:1–13.
2010. View Article : Google Scholar
|
|
23
|
Narisawa-Saito M and Kiyono T: Basic
mechanisms of high-risk human papillomavirus-induced
carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci.
98:1505–1511. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boldrini NT, Freitas LB, Coutinho AR,
Loureiro FZ, Spano LC and Miranda AE: High-grade cervical lesions
among women attending a reference clinic in Brazil: Associated
factors and comparison among screening methods. PLoS One.
9:e1021692014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazumder Indra D, Singh RK, Mitra S, Dutta
S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S and Panda CK:
Genetic and epigenetic changes of HPV16 in cervical cancer
differentially regulate E6/E7 expression and associate with disease
progression. Gynecol Oncol. 123:597–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leong CM, Doorbar J, Nindl I, Yoon HS and
Hibma MH: Loss of epidermal Langerhans cells occurs in human
papillomavirus alpha, gamma, and mu but not beta genus infections.
J Invest Dermatol. 130:472–480. 2010. View Article : Google Scholar
|
|
27
|
Tran Janco JM, Lamichhane P, Karyampudi L
and Knutson KL: Tumor-infiltrating dendritic cells in cancer
pathogenesis. J Immunol. 194:2985–2991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khaiboullina SF, Morzunov SP, Hall MR, De
Meirleir KL, Rizvanov AA and Lombardi VC: Human dendritic cells
transfected with a human papilloma virus-18 construct display
decreased mobility and upregulated cytokine production. Int J
Oncol. 43:1701–1709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fitzgerald DW, Bezak K, Ocheretina O,
Riviere C, Wright TC, Milne GL, Zhou XK, Du B, Subbaramaiah K, Byrt
E, et al: The effect of HIV and HPV coinfection on cervical COX-2
expression and systemic prostaglandin E2 levels. Cancer Prev Res
(Phila). 5:34–40. 2012. View Article : Google Scholar
|
|
30
|
Tsujii M, Kawano S, Tsuji S, Sawaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karpisheh V, Nikkhoo A, Hojjat-Farsangi M,
Namdar A, Azizi G, Ghalamfarsa G, Sabz G, Yousefi M, Yousefi B and
Jadidi-Niaragh F: Prostaglandin E2 as a potent therapeutic target
for treatment of colon cancer. Prostaglandins Other Lipid Mediat.
144:1063382019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsujii M and DuBois RN: Alterations in
cellular adhesion and apoptosis in epithelial cells overexpressing
prostaglandin endo-peroxide synthase 2. Cell. 83:493–501. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma S, Yang SC, Zhu L, Reckamp K,
Gardner B, Baratelli F, Huang M, Batra RK and Dubinett SM: Tumor
cyclooxy-genase-2/prostaglandin E2-dependent promotion of FOXP3
expression and CD4+ CD25+ T regulatory cell activities in lung
cancer. Cancer Res. 65:5211–5220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang F, Zhang R and Wang J:
Cyclooxygenase-2-Mediated Up-Regulation of Mitochondrial
Transcription Factor A Mitigates the Radio-Sensitivity of Cancer
Cells. Int J Mol Sci. 20:E12182019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Balan R, Amălinei C, Giuşcă SE, Ditescu D,
Gheorghiţă V, Crauciuc E and Căruntu ID: Immunohistochemical
evaluation of COX-2 expression in HPV-positive cervical squamous
intraepithelial lesions. Rom J Morphol Embryol. 52:39–43.
2011.PubMed/NCBI
|
|
36
|
Hara S, Kamei D, Sasaki Y, Tanemoto A,
Nakatani Y and Murakami M: Prostaglandin E synthases: Understanding
their pathophysiological roles through mouse genetic models.
Biochimie. 92:651–659. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Herfs M, Herman L, Hubert P, Minner F,
Arafa M, Roncarati P, Henrotin Y, Boniver J and Delvenne P: High
expression of PGE2 enzymatic pathways in cervical (pre)neoplastic
lesions and functional consequences for antigen-presenting cells.
Cancer Immunol Immunother. 58:603–614. 2009. View Article : Google Scholar
|
|
38
|
Mattila S, Tuominen H, Koivukangas J and
Stenbäck F: The terminal prostaglandin synthases mPGES-1, mPGES-2,
and cPGES are all overexpressed in human gliomas. Neuropathology.
29:156–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Scandella E, Men Y, Gillessen S, Förster R
and Groettrup M: Prostaglandin E2 is a key factor for CCR7 surface
expression and migration of monocyte-derived dendritic cells.
Blood. 100:1354–1361. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bruckner M, Dickel D, Singer E and Legler
DF: Converse regulation of CCR7-driven human dendritic cell
migration by prostaglandin E2 and liver X receptor
activation. Eur J Immunol. 42:2949–2958. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Legler DF, Krause P, Scandella E, Singer E
and Groettrup M: Prostaglandin E2 is generally required for human
dendritic cell migration and exerts its effect via EP2 and EP4
receptors. J Immunol. 176:966–973. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Scandella E, Men Y, Legler DF, Gillessen
S, Prikler L, Ludewig B and Groettrup M: CCL19/CCL21-triggered
signal transduction and migration of dendritic cells requires
prostaglandin E2. Blood. 103:1595–1601. 2004. View Article : Google Scholar
|
|
43
|
Shimabukuro-Vornhagen A, Liebig TM,
Koslowsky T, Theurich S and von Bergwelt-Baildon MS: The ratio
between dendritic cells and T cells determines whether
prostaglandin E2 has a stimulatory or inhibitory effect. Cell
Immunol. 281:62–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rubio MT, Means TK, Chakraverty R, Shaffer
J, Fudaba Y, Chittenden M, Luster AD and Sykes M: Maturation of
human monocyte-derived dendritic cells (MoDCs) in the presence of
prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to
protein antigens: Role of PGE2 in chemokine and cytokine expression
by MoDCs. Int Immunol. 17:1561–1572. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Spaggiari GM, Abdelrazik H, Becchetti F
and Moretta L: MSCs inhibit monocyte-derived DC maturation and
function by selectively interfering with the generation of immature
DCs: Central role of MSC-derived prostaglandin E2. Blood.
113:6576–6583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sá-Nunes A, Bafica A, Lucas DA, Conrads
TP, Veenstra TD, Andersen JF, Mather TN, Ribeiro JM and
Francischetti IM: Prostaglandin E2 is a major inhibitor of
dendritic cell maturation and function in Ixodes scapularis saliva.
J Immunol. 179:1497–1505. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ,
Chang SK, Park HC, Suh CO, Park TK and Kim BS: Overexpression of
cyclooxygenase-2 is associated with a poor prognosis in patients
with squamous cell carcinoma of the uterine cervix treated with
radiation and concurrent chemotherapy. Cancer. 95:531–539. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hugo de Almeida V, Guimarães IDS, Almendra
LR, Rondon AMR, Tilli TM, de Melo AC, Sternberg C and Monteiro RQ:
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates
resistance to cisplatin and poor survival in cervical cancer.
Oncotarget. 9:30594–30609. 2018.PubMed/NCBI
|
